Ferguson Mark K, Vigneswaran Wickii T
Department of Surgery, The University of Chicago, Chicago, Illinois 60637, USA.
Ann Thorac Surg. 2008 Apr;85(4):1158-64; discussion 1164-5. doi: 10.1016/j.athoracsur.2007.12.071.
Diffusing capacity (DLCO), an independent predictor of morbidity after major lung resection, is not used routinely in preoperative evaluation because of a perceived lack of value in patients with normal spirometry. We evaluated the potential utility of measuring DLCO for assessment of operative risk in lung resection patients with normal spirometry.
A retrospective review was conducted for patients undergoing lung resection from 1980 through 2006 to identify predictors of postoperative morbidity. Patients were divided into groups with or without chronic obstructive lung disease (COPD), defined as a ratio of forced expiratory volume in the first second to forced vital capacity of less than 0.7 or a ratio of 0.7 or greater, respectively. Analyses for each group identified covariates for three outcomes: operative mortality, pulmonary morbidity, and overall morbidity.
Of 1,046 patients in the database, 1,008 (545 men; mean age, 61.8 +/- 0.35 years) had data permitting determination of COPD status: 450 (45%) with COPD, 558 (55%) without COPD. Operations included lobectomy (752; 75%), bilobectomy (83; 8%), and pneumonectomy (173; 17%). Overall mortality, pulmonary morbidity, and overall morbidity incidences were 59 (5.8%), 140 (14.0%), and 311 (31.4%), respectively. Pulmonary morbidity and operative mortality were related to postoperative predicted DLCO, age, and performance status in patients with and without COPD. The postoperative predicted DLCO was the single strongest predictor of pulmonary morbidity and operative mortality in both patient groups. Overall complications were related to postoperative predicted DLCO only in the COPD group.
Diffusing capacity is an important predictor of postoperative morbidity after lung resection even in patients with normal spirometry. Routine measurement of DLCO, regardless of spirometric findings, can help predict risk in candidates for major lung resection.
弥散功能(DLCO)是肺大切除术后发病的独立预测指标,但由于认为其在肺功能正常的患者中缺乏价值,故未常规用于术前评估。我们评估了测量DLCO对评估肺功能正常的肺切除患者手术风险的潜在效用。
对1980年至2006年接受肺切除的患者进行回顾性研究,以确定术后发病的预测因素。患者被分为有或无慢性阻塞性肺疾病(COPD)组,分别定义为第一秒用力呼气量与用力肺活量之比小于0.7或大于或等于0.7。对每组进行分析,确定三个结局的协变量:手术死亡率、肺部发病率和总体发病率。
数据库中的1046例患者中,1008例(545例男性;平均年龄61.8±0.35岁)有数据可确定COPD状态:450例(45%)有COPD,558例(55%)无COPD。手术包括肺叶切除术(752例;75%)、双肺叶切除术(83例;8%)和全肺切除术(173例;17%)。总体死亡率、肺部发病率和总体发病率分别为59例(5.8%)、140例(14.0%)和311例(31.4%)。有和无COPD的患者中,肺部发病率和手术死亡率与术后预测的DLCO、年龄和体能状态有关。术后预测的DLCO是两组患者肺部发病率和手术死亡率的最强单一预测指标。总体并发症仅在COPD组与术后预测的DLCO有关。
即使在肺功能正常的患者中,弥散功能也是肺切除术后发病的重要预测指标。无论肺功能检查结果如何,常规测量DLCO有助于预测肺大切除候选者的风险。